These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

405 related items for PubMed ID: 17665487

  • 1. Minimal disease activity, remission, and the long-term outcomes of rheumatoid arthritis.
    Wolfe F, Rasker JJ, Boers M, Wells GA, Michaud K.
    Arthritis Rheum; 2007 Aug 15; 57(6):935-42. PubMed ID: 17665487
    [Abstract] [Full Text] [Related]

  • 2. The prevalence of clinical remission in RA patients treated with anti-TNF: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry.
    de Punder YM, Fransen J, Kievit W, Houtman PM, Visser H, van de Laar MA, van Riel PL.
    Rheumatology (Oxford); 2012 Sep 15; 51(9):1610-7. PubMed ID: 22539487
    [Abstract] [Full Text] [Related]

  • 3. Remission in rheumatoid arthritis: wishful thinking or clinical reality?
    Sesin CA, Bingham CO.
    Semin Arthritis Rheum; 2005 Dec 15; 35(3):185-96. PubMed ID: 16325659
    [Abstract] [Full Text] [Related]

  • 4. Short-term outcome after anti-tumor necrosis factor-alpha therapy in rheumatoid arthritis: do we need to revise our assessment criteria?
    El Miedany Y, Youssef SS, El Gaafary M.
    J Rheumatol; 2006 Mar 15; 33(3):490-7. PubMed ID: 16511918
    [Abstract] [Full Text] [Related]

  • 5. Minimal disease activity for rheumatoid arthritis: a preliminary definition.
    Wells GA, Boers M, Shea B, Brooks PM, Simon LS, Strand CV, Aletaha D, Anderson JJ, Bombardier C, Dougados M, Emery P, Felson DT, Fransen J, Furst DE, Hazes JM, Johnson KR, Kirwan JR, Landewé RB, Lassere MN, Michaud K, Suarez-Almazor M, Silman AJ, Smolen JS, Van der Heijde DM, van Riel PL, Wolfe F, Tugwell PS.
    J Rheumatol; 2005 Oct 15; 32(10):2016-24. PubMed ID: 16206362
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Most people over age 50 in the general population do not meet ACR remission criteria or OMERACT minimal disease activity criteria for rheumatoid arthritis.
    Sokka T, Mäkinen H, Hannonen P, Pincus T.
    Rheumatology (Oxford); 2007 Jun 15; 46(6):1020-3. PubMed ID: 17405761
    [Abstract] [Full Text] [Related]

  • 8. Patients with moderate rheumatoid arthritis (RA) achieve better disease activity states with etanercept treatment than patients with severe RA.
    Keystone E, Freundlich B, Schiff M, Li J, Hooper M.
    J Rheumatol; 2009 Mar 15; 36(3):522-31. PubMed ID: 19228659
    [Abstract] [Full Text] [Related]

  • 9. The good initial response to therapy with a combination of traditional disease-modifying antirheumatic drugs is sustained over time: the eleven-year results of the Finnish rheumatoid arthritis combination therapy trial.
    Rantalaiho V, Korpela M, Hannonen P, Kautiainen H, Järvenpää S, Leirisalo-Repo M, Hakala M, Puolakka K, Julkunen H, Luosujärvi R, Möttönen T, FIN-RACo Trial Group.
    Arthritis Rheum; 2009 May 15; 60(5):1222-31. PubMed ID: 19404945
    [Abstract] [Full Text] [Related]

  • 10. The problem of rheumatoid arthritis disease activity and remission in clinical practice.
    Shaver TS, Anderson JD, Weidensaul DN, Shahouri SH, Busch RE, Mikuls TR, Michaud K, Wolfe F.
    J Rheumatol; 2008 Jun 15; 35(6):1015-22. PubMed ID: 18412311
    [Abstract] [Full Text] [Related]

  • 11. Tolerance and effectiveness of anti-tumor necrosis factor alpha therapies in elderly patients with rheumatoid arthritis: a population-based cohort study.
    Genevay S, Finckh A, Ciurea A, Chamot AM, Kyburz D, Gabay C, Physicians of the Swiss Clinical Quality Management Program for Rheumatoid Arthritis.
    Arthritis Rheum; 2007 May 15; 57(4):679-85. PubMed ID: 17471545
    [Abstract] [Full Text] [Related]

  • 12. Current tumor necrosis factor-alpha inhibitor use is associated with a higher probability of remissions in patients with rheumatoid arthritis.
    Liang GC, Cordero M, Dyer A, Chang RW.
    J Rheumatol; 2005 Sep 15; 32(9):1662-5. PubMed ID: 16142857
    [Abstract] [Full Text] [Related]

  • 13. Prevalence of and predictive factors for sustained disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: results from two large early arthritis cohorts.
    van der Woude D, Young A, Jayakumar K, Mertens BJ, Toes RE, van der Heijde D, Huizinga TW, van der Helm-van Mil AH.
    Arthritis Rheum; 2009 Aug 15; 60(8):2262-71. PubMed ID: 19644846
    [Abstract] [Full Text] [Related]

  • 14. Most patients receiving routine care for rheumatoid arthritis in 2001 did not meet inclusion criteria for most recent clinical trials or american college of rheumatology criteria for remission.
    Sokka T, Pincus T.
    J Rheumatol; 2003 Jun 15; 30(6):1138-46. PubMed ID: 12784382
    [Abstract] [Full Text] [Related]

  • 15. Remission by composite scores in rheumatoid arthritis: are ankles and feet important?
    Kapral T, Dernoschnig F, Machold KP, Stamm T, Schoels M, Smolen JS, Aletaha D.
    Arthritis Res Ther; 2007 Jun 15; 9(4):R72. PubMed ID: 17662115
    [Abstract] [Full Text] [Related]

  • 16. Influence of age on the outcome of antitumour necrosis factor alpha therapy in rheumatoid arthritis.
    Radovits BJ, Kievit W, Fransen J, van de Laar MA, Jansen TL, van Riel PL, Laan RF.
    Ann Rheum Dis; 2009 Sep 15; 68(9):1470-3. PubMed ID: 19015210
    [Abstract] [Full Text] [Related]

  • 17. Utilization trends of tumor necrosis factor inhibitors among patients with rheumatoid arthritis in a United States observational cohort study.
    Lee SJ, Chang H, Yazici Y, Greenberg JD, Kremer JM, Kavanaugh A.
    J Rheumatol; 2009 Aug 15; 36(8):1611-7. PubMed ID: 19369454
    [Abstract] [Full Text] [Related]

  • 18. Is the disease course of rheumatoid arthritis becoming milder? Time trends since 1985 in an inception cohort of early rheumatoid arthritis.
    Welsing PM, Fransen J, van Riel PL.
    Arthritis Rheum; 2005 Sep 15; 52(9):2616-24. PubMed ID: 16142762
    [Abstract] [Full Text] [Related]

  • 19. "5D" Outcome in 52 patients with rheumatoid arthritis surviving 20 years after initial disease modifying antirheumatic drug therapy.
    Capell H, McCarey D, Madhok R, Hampson R.
    J Rheumatol; 2002 Oct 15; 29(10):2099-105. PubMed ID: 12375318
    [Abstract] [Full Text] [Related]

  • 20. Frequency and duration of clinical remission in patients with peripheral psoriatic arthritis requiring second-line drugs.
    Cantini F, Niccoli L, Nannini C, Cassarà E, Pasquetti P, Olivieri I, Salvarani C.
    Rheumatology (Oxford); 2008 Jun 15; 47(6):872-6. PubMed ID: 18400836
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.